Research and Markets (http://www.researchandmarkets.com/research/5bzpq8/thrombosis) has announced the addition of the "Thrombosis - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombosis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Thrombosis Overview
- Therapeutics Development
- Pipeline Products for Thrombosis - Overview
- Pipeline Products for Thrombosis - Comparative Analysis
- Thrombosis - Therapeutics under Development by Companies
- Thrombosis - Therapeutics under Investigation by Universities/Institutes
- Thrombosis - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Thrombosis - Products under Development by Companies
- Thrombosis - Products under Investigation by Universities/Institutes
- Thrombosis - Companies Involved in Therapeutics Development
- 3SBio Inc.
- Antibe Therapeutics, Inc.
- Archemix Corp.
- Arena Pharmaceuticals, Inc.
- Armetheon, Inc.
- Arrowhead Research Corporation
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bayer AG
- Bristol-Myers Squibb Company
- Cardax Pharmaceuticals, Inc.
- Cereno Scientific AB
- China Biologic Products, Inc.
- Daewoong Pharmaceutical Co., Ltd.
- Daiichi Sankyo Company, Limited
- Dyax Corp.
- Eisai Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- GlycoMimetics, Inc.
- Green Cross Corporation
- Johnson & Johnson
- Laboratorios Farmaceuticos Rovi, S.A.
- LG Life Science LTD.
- Lipicard Technologies Limited
- Merrion Pharmaceuticals Plc
- Pfizer Inc.
- PLx Pharma Inc.
- Portola Pharmaceuticals, Inc.
- Prothix BV
- Sagene Pharmaceuticals, Inc.
- Sanofi
- SciFluor Life Sciences, LLC
- The International Biotechnology Center (IBC) Generium
- Zedira GmbH
- Zydus Cadila Healthcare Limited
For more information visit http://www.researchandmarkets.com/research/5bzpq8/thrombosis
View source version on businesswire.com: http://www.businesswire.com/news/home/20160118005509/en/
